Greece Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Greece Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape

Summary

GlobalData, the industry analysis specialist, has released its latest report “Greece Healthcare (Pharma and Medical Devices) Market Analysis, Regulatory, Reimbursement and Competitive Landscape”. The report is an essential source of information on analysis of the healthcare, regulatory and reimbursement landscape in Greece. It identifies the key trends in the country’s healthcare market and provides insights into its demographic, regulatory and reimbursement landscape, and healthcare infrastructure. Most importantly, the report provides valuable insights into the trends and segmentation of its pharmaceutical and medical device markets. It uses data and information sourced from proprietary databases, secondary research, and in-house analysis by GlobalData’s team of industry experts.

The Greek pharmaceutical market increased from $7.2 billion in 2015 to $9.4 billion in 2021 at a Compound Annual Growth Rate (CAGR) of 4.6%. The overall market is forecast to be $11.2 billion in 2025. Greek pharma manufacturers have announced investment plans of $1 billion for the period 2022-26 for increasing the production of drugs and research. Greece’s medical devices market was valued at $1.3 billion in 2016, which increased at a CAGR of 2% to reach $1.5 billion in 2021. The US, Germany, Italy, and, to a lesser extent, the Netherlands, France, the UK, and Luxembourg are major suppliers of medical equipment to Greece. Greece's economy is import-dependent, with no substantial non-tariff impediments to US exports. Under Article 3 of Law 4675/2020, the Greek government launched the National Action Plan for Public Health strategy (2021-25) in 2020, with the goal of continuously improving the population's health and quality of life through the promotion of cross-sectoral cooperation to ensure better public health. On January 31, 2022, a new Clinical Trials Information Method (CTIS) was launched to provide a secure, rapid, and efficient system for clinical data registration and review.

Scope

The report provides information on the healthcare, regulatory, and reimbursement landscape in Greece, and includes -

• An overview of the pharmaceutical and medical device markets, comprising market size, segmentation, and key drivers and barriers.
• Profiles and SWOT analyses of the major players in the pharmaceutical market: Sanofi, Novartis, GlaxoSmithKline (GSK), Pfizer, and Lavipharm.
• Profiles and SWOT analyses of the major players in the medical device market: Abbott, Fresenius, GE Healthcare, Alcon, and Roche.
• An insightful review of the COVID-19 epidemiology, COVID-19 impact and developments in healthcare market, HealthTech landscape, reimbursement, and regulatory landscape, with analysis covering details of the country’s healthcare reimbursement process, regulatory agencies and the approval processes for new drugs and medical devices.
• Detailed analysis of the country’s healthcare policy highlights, demographics, healthcare infrastructure and healthcare expenditure.
• An overview of the opportunities for and challenges to growth in the Greece healthcare market.

Reasons to Buy

This report will enhance your decision-making capability by allowing you to -

• Develop business strategies by understanding the trends shaping and driving the Greece healthcare market
• Drive revenues by understanding the key trends, reimbursement and regulatory policies, pharmaceutical market segments and companies likely to impact the Greece healthcare market in the future
• Formulate effective sales and marketing strategies by understanding the competitive landscape and analyzing competitors’ performance
• Organize your sales and marketing efforts by identifying the market categories and segments that present the most opportunities for consolidation, investment, and strategic partnership